International Journal of Drug Delivery Technology
Volume 14, Issue 2

Effect of Inhaler Technique Health Education in Improving Symptoms and Lung Function in COPD Outpatient in a Private Hospital in Gresik, Indonesia: Pilot Studies

Amelia Lorensia1*, Soedarsono2, Rivan Virlando Suryadinata3, Havida Ainin Badri4

1 Department of Clinical-Community Pharmacy, Faculty of Pharmacy, Universitas Surabaya, Jl. Raya Kalirungkut, Surabaya, Indonesia.

2 Department of Pulmonology & Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.

3 Department of Public Health, Faculty of Medical, Universitas Surabaya, Jl. Raya Kalirungkut, Surabaya, Indonesia.

4 Faculty of Pharmacy, Universitas Surabaya, Jl. Raya Kalirungkut, Surabaya, Indonesia. 

Received: 25th September, 2023; Revised: 26th May, 2024; Accepted: 29th May, 2024; Available Online: 25th June, 2024 

ABSTRACT

Inhalers are the most effective therapy in the treatment of Chronic obstructive pulmonary disease (COPD). Research shows that a large number of COPD patients do not use inhalers properly. Incorrect inhaler use technique can reduce drug delivery and poor disease control. Education on how to use inhalers is an important part of COPD management. The study was conducted to determine the effect of education on symptom assessment, lung function assessment and inhaler use skill assessment in COPD patients. The research was in the form of a pre-experimental one-group pre-test post-test. The results showed that there was a significant difference in the effect of education on how to use the inhaler on the assessment of symptoms (p = 0.000), a significant difference in the assessment of lung function (p = 0.001) and a significant difference in the assessment of skills in using the inhaler (p = 0.000). Education on how to use inhalers has an influence on the assessment of symptoms, lung function and skills in using inhalers in COPD patients.

Keywords: COPD, inhaler, CAT, FEV1/FVC ratio.

International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.2.26

How to cite this article: Lorensia A, Soedarsono, Suryadinata RV, Badri HA. Effect of Inhaler Technique Health Education in Improving Symptoms and Lung Function in COPD Outpatient in a Private Hospital in Gresik, Indonesia: Pilot Studies. International Journal of Drug Delivery Technology. 2024;14(2):768-776.

REFERENCES

  1. Szalontai K, Gémes N, Furák J, Varga T, Neuperger P, Balog JÁ, Puskás LG, Szebeni Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer. J Clin Med. 2021;10(13):2889. DOI: 10.3390/jcm10132889.
  2. Fernández-García A, Pérez-Ríos M, Fernández-Villar A, Naveira G, Candal-Pedreira C, Santiago-Pérez MI, Represas-Represas C, Malvar-Pintos A, Cerdeira-Caramés S, Ruano-Raviña A. Four Decades of COPD Mortality Trends: Analysis of Trends and Multiple Causes of Death. J Clin Med. 2021;10(5):1117. DOI: 3390/jcm10051117.
  3. Cheng SL, Lin CH. COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences. Diagnostics (Basel). 2021;11(7):1153. DOI: 3390/diagnostics11071153.
  4. Manian Chronic obstructive pulmonary disease classification, phenotypes and risk assessment. J Thorac Dis. 2019;11(Suppl 14):S1761-S1766. DOI: 10.21037/jtd.2019.05.10.
  5. Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, Montes de Oca M, Papi A, Sin DD, Han MK, Agusti A. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Respir Crit Care Med. 2022;206(11):1317-25. DOI: 10.1164/rccm.202204-0671PP.
  6. Lorensia A, Wahyudi M, Mayzika NA. Effectiveness of Fish Oil Containing Omega-3 In Improving Symptoms And Lung Function In Asthma Outpatient In Surabaya, Indonesia. International Journal Of Pharmaceutical Quality 2018;9(3):260-6.
  7. Al-Tufaily Y, Hussein QN, Hussein Zinc Status in children with bronchial asthma. International Journal of Drug Delivery Technology. 2022;12(2):851-4. DOI: 10.25258/ijddt.12.2.69.
  8. Fernandes FLA, Cukier A, Camelier AA, Fritscher CC, Costa CHD, Pereira EDB, Godoy I, Cançado JED, Romaldini JG, Chatkin JM, Jardim JR, Rabahi MF, Nucci MCNM, Sales MDPU, Castellano MVCO, Aidé MA, Teixeira PJZ, Maciel R, Corrêa RA, Stirbulov R, Athanazio RA, Russo R, Minamoto ST, Lundgren FLC. Recommendations for the pharmacological treatment of COPD: questions and J Bras Pneumol. 2017;43(4):290-301. DOI: 10.1590/S1806-37562017000000153.
  9. Yawn BP, Mintz ML, Doherty DE. GOLD in Practice: Chronic Obstructive Pulmonary Disease Treatment and Management in the Primary Care Setting. Int J Chron Obstruct Pulmon Dis. 2021;16:289-99. DOI: 10.2147/COPD.S222664.
  10. Kumari CS, Seethalakshmi K. Synthesizing Radiological Insights: Enhancing Lung Disease Classification through Multimodal Imaging. International Journal Of Pharmaceutical Quality Assurance. 2023;14(2):1126 -35. DOI: 10.25258/ 14.4.47.
  11. Cazzola M, Ora J, Calzetta L, Rogliani P, Matera The future of inhalation therapy in chronic obstructive pulmonary disease. Curr Res Pharmacol Drug Discov. 2022;3:100092. DOI: 10.1016/j. crphar.2022.100092.
  12. Borghardt JM, Kloft C, Sharma Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes. Can Respir J. 2018;2018:2732017. DOI: 10.1155/2018/2732017.
  13. Ratnaparkhi MP, Kamble OV, Salvankar SS, Shinde SR, Kulkarni GM, Shewale AB, Kadam DD, Shaikh Formulation and evaluation of moxifloxacin dry powder inhaler combined with mucolytic agent for pulmonary disease. International Journal of Drug Delivery Technology. 2023;13(3):818-24. DOI: 10.25258/ijddt.13.3.07.
  14. Gregoriano C, Dieterle T, Breitenstein AL, Dürr S, Baum A, Maier S, Arnet I, Hersberger KE, Leuppi Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Respir Res. 2018;19(1):237. DOI: 10.1186/s12931-018-0936-3.
  15. Bosnic-Anticevich S, Chrystyn H, Costello RW, Dolovich MB, Fletcher MJ, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes. Int J Chron Obstruct Pulmon Dis. 2019;14:1739. DOI: 10.2147/COPD.S117196.
  16. Padmanabhan M, Tamilarasu K, Rajaram M, Batmanabane Inadequate inhaler technique, an everlasting problem, is associated with poor disease control - A cross sectional study. Adv Respir Med. 2019;87(4):217-25. DOI: 10.5603/ARM. a2019.0021.
  17. Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, Dekhuijzen Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19(1):10. DOI: 10.1186/s12931-017-0710-y.
  18. Stridsman C, Svensson M, Johansson Strandkvist V, Hedman L, Backman H, Lindberg A. The COPD Assessment Test (CAT) can screen for fatigue among patients with Ther Adv Respir Dis. 2018;12:1753466618787380. DOI: 10.1177/1753466618787380.
  19. Sari CP, Hanifah S, Rosdiana R, Anisa The COPD (Chronic Obstructive Pulmonary Disease) Assessment Test: Assessment of Therapeutic Outcomes of Patients at Private Hospitals in Yogyakarta. J Pharm Bioallied Sci. 2020;12(Suppl 2):S821-S825. DOI: 10.4103/jpbs.JPBS_302_19.
  20. Gil HI, Zo S, Jones PW, Kim BG, Kang N, Choi Y, Cho HK, Kang D, Cho J, Park HY, Shin SH. Clinical Characteristics of COPD Patients According to COPD Assessment Test (CAT) Score Level: Cross-Sectional Int J Chron Obstruct Pulmon Dis. 2021;16:1509-17. DOI: 10.2147/COPD.S297089.
  21. Stanford RH, Tabberer M, Kosinski M, Johnson PT, White J, Carlyle M, Tillery Assessment of the COPD Assessment Test Within U.S. Primary Care. Chronic Obstr Pulm Dis. 2020;7(1):26-37. DOI: 10.15326/jcopdf.7.1.2019.0135.
  22. Torén K, Schiöler L, Lindberg A, Andersson A, Behndig AF, Bergström G, Blomberg A, Caidahl K, Engvall JE, Eriksson MJ, Hamrefors V, Janson C, Kylhammar D, Lindberg E, Lindén A, Malinovschi A, Lennart Persson H, Sandelin M, Eriksson Ström J, Tanash H, Vikgren J, Johan Östgren C, Wollmer P, Sköld The ratio FEV1 /FVC and its association to respiratory symptoms-A Swedish general population study. Clin Physiol Funct Imaging. 2021;41(2):181-91. DOI: 10.1111/cpf.12684.
  23. Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K, Pantazopoulos I. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med. 2021;31(1):23. DOI: 10.1038/s41533-021-00236-w.
  24. Ariawan WP, Yunus F, Damayanti T, Nurwidya Rate of Forced Expiratory Volume in One Second and Forced Expiratory Volume in One Second/Forced Vital Capacity Decline among Indonesian Patients with Chronic Obstructive Pulmonary Disease after a Year of Treatment. Int J Appl Basic Med Res. 2019;9(2):95-9. DOI: 10.4103/ijabmr.IJABMR_254_18.
  25. Sanaullah T, Khan S, Masoom A, Mandokhail ZK, Sadiqa A, Malik MI. Inhaler Use Technique in Chronic Obstructive Pulmonary Disease Patients: Errors, Practices and Barriers. Cureus. 2020;12(9):e10569. DOI: 10.7759/cureus.10569.
  26. Lorensia A, Puspitasari MD, Soedarsono, Suryadinata RV. Cost-Effectiveness Analysis of Budesonide/Formoterol and Fluticasone/Salmeterol for Stable Chronic Obstructive Lung J Respirol Indones. 2022;42(4):289–97. DOI: 10.36497/ jri.v42i4.378.
  27. Lorensia A, Suryadinata RV, Savitri KYD. COPD Symptoms and Risk Factors of Respiratory Disorders in Builders. Kemas. 2022;17(4):552-65. DOI: 15294/kemas.v17i4.28195.
  28. Yang CL, Chang SH, Chen YF, Chen CY. Assessment of the technique in different inhalation devices and investigating the factors associated with inhaler misuse in COPD patients. European Respiratory Journal 2017;50:PA525; DOI: 10.1183/1393003. congress-2017.PA525.
  29. Çakmaklı S, Özdemir A, Fırat H, Aypak An evaluation of the use of inhalers in asthma and chronic obstructive pulmonary disease. J Taibah Univ Med Sci. 2023;18(4):860-7. DOI: 10.1016/j. jtumed.2023.01.001.
  30. Volerman A, Carpenter D, Press What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions. Expert Rev Respir Med. 2020;14(8):791-805. DOI: 10.1080/17476348.2020.1754800.
  31. Lorensia A, Yudiarso A, Kusdiyanti DD Damayanti Pharmacists’ perceptions of pharmaceutical services in asthma inhaled medication in Surabaya: A mixed-method study. Journal of Applied Pharmaceutical Science. 2023;13(1):221-31.
  32. Tülüce D, Köktürk N, Geniş B, Kayalar A, Gürhan N, Kutlutürkan S. The Effect of Education and Motivational Interviewing on COPD Management and Outcome Parameters in COPD Patients. Turk Thorac J. 2021;22(5):399-406. DOI: 5152/TurkThoracJ.2021.0004.
  33. Petite SE, Hess MW, Wachtel H. The Role of the Pharmacist in Inhaler Selection and Education in Chronic Obstructive Pulmonary J Pharm Technol. 2021;37(2):95-106. DOI: 10.1177/8755122520937649.
  34. Rahayu SA, Widianto S, Defi IR, Abdulah Role of Pharmacists in the Interprofessional Care Team for Patients with Chronic Diseases. J Multidiscip Healthc. 2021;14:1701-10. DOI: 10.2147/ JMDH.S309938.
  35. Hayoo K, Chung WY, Park JH, Hwang SC, Kim TE, Jung M, et al. Short-term Evaluation of a Comprehensive Education Program Including InhalerTraining and Disease Management on Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Disease. 2017;80:377-84.
  36. Nguyen TS, Nguyen TLH, Pam TTV, Hua S, Chau.Q. ChuenLi S.Pharmacists’ training to improve inhaler technique of patients with COPD in International of COPD. 2018;13:1863-72.
  37. Jang JG, Kim JS, Chung JH, Shin KC, Ahn JH, Lee MS, et al. Comprehensive Effects of Organized Education for Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease. 2019;14:2603-9.
  38. Lorensia A, Setiawan B, Maranatha D, Yudiarso Effectiveness of Education Based Information-Motivation-Behavioral Skill (IMB) Model of Improving Knowledge, Motivation, and Performance Demonstration Metered-Dose Inhaler (MDI) to Community Pharmacists in Surabaya. International Journal of Pharmaceutical and Clinical Research. 2017;9(7):485-95.
  39. Rehman AU, Hassali MAA, Harun SN, Abbas S, Muneswarao J, Ali IABH, Hussain Validation and clinical interpretation of the St George’s respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD. Health Qual Life Outcomes. 2020;18(1):138. DOI: 10.1186/s12955-020-01393-1.
  40. Choi JY, Rhee CK. Diagnosis and Treatment of Early Chronic Obstructive Lung Disease (COPD). J Clin 2020;9(11):3426. DOI: 10.3390/jcm9113426.
  41. Singh D. Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease. Tuberc Respir Dis (Seoul). 2017;80(4):317-24. DOI: 10.4046/trd.2017.0080.
  42. Ekström M, Mannino Research race-specific reference values and lung function impairment, breathlessness and prognosis: Analysis of NHANES 2007-2012. Respir Res. 2022;23(1):271. DOI: 10.1186/s12931-022-02194-4.
  43. Haynes JM. Basic spirometry testing and interpretation for the primary care Can J Respir Ther. 2018;54(4):10.29390/ cjrt-2018-017. DOI: 10.29390/cjrt-2018-017.
  44. Aytac SO, Kilic SP, Ovayolu Effect of inhaler drug education on fatigue, dyspnea severity, and respiratory function tests in patients with COPD. Patient Educ Couns. 2020;103(4):709- 716. doi: 10.1016/j.pec.2019.11.003. Epub 2019 Nov 5. PMID:31733985.
  45. Maricoto T, Madanelo S, Rodrigues L, Teixeira G, Valente C, Andrade L, et al. Educational Interventions to Improve Inhaler Techniques and Their Impact on Asthma and COPD Control : a pilot effectiveness- implementation trial.J Bras Pneumol. 2016; 6(42):440-3.
  46. Ruud KW, Ronningen SW, Faksvag PK, Ariansen H, Hovland Evaluation of a structured pharmaciest-Ied inhalation technique assessment service for patients with asthma and COPD in Norwegian pharmacies. Patient Education and Counseling. 2018:1828-37.
  47. Liang CY, Chen YJ, Sheu SM, Tsai CF, Chen W. Misuse of inhalers among COPD patients in a community hospital in Taiwan. International Journal of COPD. 2018:13:1309-16.
  48. Li H, Chen Y, Zhang Z, Dong X, Zhang G, Zhang H. Handling of Diskus Dry Powder Inhaler in Chinese Chronic Obstructive Pulmonary Disease Patients. Journal Of Aerosol Medicine And Pulmonary Drug Deliver. 2014;27(3):219-227
  49. Lorensia A, Queljoe DD, Karina BL, Heru Studi Kelengkapan Penjelasan Cara Penggunaan Sediaan Controller Inhaler (Kombinasi Kortikosteroid dengan Beta-2 Agonis) Jenis Diskus dan Turbuhaler Oleh Apoteker di Apotek. Jurnal Ilmiah Manuntung.2016;2(2):137-146.
  50. Ocakli B, Ozmen I, Tuncay EA, Gungor S, Altinoz H, Adiguzel N, et al. AComparative analysis of errors in inhaler technique among COPD versus asthma patients. International Journal of COPD. 2018:13:2941-7.
  51. Zazuli Z, Ramasamy K, Adnyana Evaluasi Teknik Penggunaan Inhaler Pada Pasien Asma dan PPOK di Suatu Sarana Pelayanan Kesehatan Primer: Suatu Studi Pendahuluan di Selangor Malaysia. JMPF. 2018;8(2):80-9.